Literature DB >> 17479285

Global gene expression profiling of formalin-fixed paraffin-embedded tumor samples: a comparison to snap-frozen material using oligonucleotide microarrays.

Matthias Frank1, Claudia Döring, Dirk Metzler, Susan Eckerle, Martin-Leo Hansmann.   

Abstract

Oligonucleotide microarrays are widely used to investigate gene expression in a large-scale approach. A major limitation is the dependency on frozen material to obtain high-quality ribonucleic acid because most clinical specimens are formalin-fixed and paraffin-embedded (FFPE). The ability to analyze these samples using microarrays would enlarge the investigable sample stocks manifold. We conducted a comparison of snap-frozen and FFPE tissues investigating two malignomas. Gene expression profiles were obtained from both materials of the tumors. Independently processed triplicates of snap-frozen and FFPE specimen, respectively, were two-round-amplified and hybridized on Affymetrix GeneChips (Palo Alto, CA, USA). Differentially expressed genes were identified in both FFPE and frozen material. All replicates had a correlation coefficient (R) of greater than 0.95 after normalization. Only direct comparison of FFPE to frozen replicates resulted in a mean R of 0.86, rendering a "mixed" investigation unfeasible. More than 50% (419 genes) of the more than fivefold differentially expressed genes (800 in FFPE, 685 in frozen material) were detected concomitantly regardless of the material used, which is similar to other comparisons of different gene expression analysis platforms. Thus, global gene expression analyses using solely FFPE material seem to be feasible with nearly comparable results to frozen tissue studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479285     DOI: 10.1007/s00428-007-0412-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 2.  Microarray platforms--comparisons and contrasts.

Authors:  Gary Hardiman
Journal:  Pharmacogenomics       Date:  2004-07       Impact factor: 2.533

3.  High-accuracy amplification of nanogram total RNA amounts for gene profiling.

Authors:  Marc Kenzelmann; Ralf Klären; Manfred Hergenhahn; Mahnaz Bonrouhi; Hermann-Josef Gröne; Wolfgang Schmid; Günther Schütz
Journal:  Genomics       Date:  2004-04       Impact factor: 5.736

4.  Patient-based cross-platform comparison of oligonucleotide microarray expression profiles.

Authors:  Joerg Schlingemann; Negusse Habtemichael; Carina Ittrich; Grischa Toedt; Heidi Kramer; Markus Hambek; Rainald Knecht; Peter Lichter; Roland Stauber; Meinhard Hahn
Journal:  Lab Invest       Date:  2005-08       Impact factor: 5.662

5.  Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples.

Authors:  N Masuda; T Ohnishi; S Kawamoto; M Monden; K Okubo
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

6.  Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization.

Authors:  Janine Antonov; Darlene R Goldstein; Andrea Oberli; Anna Baltzer; Marco Pirotta; Achim Fleischmann; Hans J Altermatt; Rolf Jaggi
Journal:  Lab Invest       Date:  2005-08       Impact factor: 5.662

7.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Authors:  Ralf Küppers; Ulf Klein; Ines Schwering; Verena Distler; Andreas Bräuninger; Giorgio Cattoretti; Yuhai Tu; Gustavo A Stolovitzky; Andrea Califano; Martin-Leo Hansmann; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.

Authors:  Richard W Tothill; Adam Kowalczyk; Danny Rischin; Alex Bousioutas; Izhak Haviv; Ryan K van Laar; Paul M Waring; John Zalcberg; Robyn Ward; Andrew V Biankin; Robert L Sutherland; Susan M Henshall; Kwun Fong; Jonathan R Pollack; David D L Bowtell; Andrew J Holloway
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

9.  Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

Authors:  Stefano Monti; Kerry J Savage; Jeffery L Kutok; Friedrich Feuerhake; Paul Kurtin; Martin Mihm; Bingyan Wu; Laura Pasqualucci; Donna Neuberg; Ricardo C T Aguiar; Paola Dal Cin; Christine Ladd; Geraldine S Pinkus; Gilles Salles; Nancy Lee Harris; Riccardo Dalla-Favera; Thomas M Habermann; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2004-11-18       Impact factor: 22.113

10.  Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.

Authors:  Marshall S Scicchitano; Deidre A Dalmas; Melissa A Bertiaux; Shawn M Anderson; Leah R Turner; Roberta A Thomas; Rossana Mirable; Rogely W Boyce
Journal:  J Histochem Cytochem       Date:  2006-07-24       Impact factor: 2.479

View more
  30 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

3.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

4.  Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.

Authors:  Raji Pillai; Rebecca Deeter; C Ted Rigl; J Scott Nystrom; Meredith Halks Miller; Ljubomir Buturovic; W David Henner
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

5.  Comparison of histopathological and gene expression-based typing of cancer of unknown primary.

Authors:  Lars Morawietz; Arno Floore; Lisette Stork-Sloots; Gunnar Folprecht; Reinhard Buettner; Anja Rieger; Manfred Dietel; Gerdt Huebner
Journal:  Virchows Arch       Date:  2009-12-10       Impact factor: 4.064

Review 6.  RNA expression analysis from formalin fixed paraffin embedded tissues.

Authors:  Susan M Farragher; Austin Tanney; Richard D Kennedy; D Paul Harkin
Journal:  Histochem Cell Biol       Date:  2008-08-05       Impact factor: 4.304

7.  Development of a microarray platform for FFPET profiling: application to the classification of human tumors.

Authors:  Sven Duenwald; Mingjie Zhou; Yanqun Wang; Serguei Lejnine; Amit Kulkarni; Jaime Graves; Ryan Smith; John Castle; George Tokiwa; Bernard Fine; Hongyue Dai; Thomas Fare; Matthew Marton
Journal:  J Transl Med       Date:  2009-07-28       Impact factor: 5.531

8.  [Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification].

Authors:  L Morawietz; A Floore; L Stork-Sloots; G Folprecht; R Buettner; A Rieger; M Dietel; G Huebner
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

9.  3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.

Authors:  Andrew H Beck; Ziming Weng; Daniela M Witten; Shirley Zhu; Joseph W Foley; Phil Lacroute; Cheryl L Smith; Robert Tibshirani; Matt van de Rijn; Arend Sidow; Robert B West
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas.

Authors:  Grazyna Fedorowicz; Steve Guerrero; Thomas D Wu; Zora Modrusan
Journal:  BMC Med Genomics       Date:  2009-05-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.